A case of acute cerebral aspergillosis complicating influenza A/H1N1pdm 2009

Infection and Chemotherapy

Volumn 45, Issue 2, 2013, Pages 225-229

  Jae Kim, Min ^a   Kim, Min Kyung ^a   Kang, Chang Kyung ^a   Jun, Kang Il ^a   Bang, Ji Hwan ^b   Park, Sang Won ^b   Oh, Myoung Don ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

Author keywords

Brain abscess; Central nervous system; Diabetes mellitus; Influenza; Invasive aspergillosis

Indexed keywords

ACICLOVIR; AMANTADINE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; C REACTIVE PROTEIN; CEFTRIAXONE; CREATININE; HEMOGLOBIN A1C; INSULIN; LEVOFLOXACIN; MEROPENEM; NAFCILLIN; OSELTAMIVIR; VORICONAZOLE;

2009 H1N1 INFLUENZA; ADULT; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS FUMIGATUS; BACTERIAL PNEUMONIA; BLOOD PRESSURE; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CEREBELLUM; CLOSTRIDIUM DIFFICILE INFECTION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CREATININE BLOOD LEVEL; DIABETIC KETOACIDOSIS; FLUID RESUSCITATION; FRONTAL CORTEX; FUNGUS CULTURE; HOSPITALIZATION; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTENSIVE CARE; MALE; MENINGITIS; MENTAL DISEASE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS PNEUMONIA; NEUROPATHOLOGY; PARIETAL CORTEX; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SORE THROAT; SUBCORTEX; SURGICAL DRAINAGE; THERAPY; TRACHEAL ASPIRATION PROCEDURE; TREATMENT DURATION; VIRUS ENCEPHALITIS; WHITE MATTER;

EID: 84884273556     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2013.45.2.225     Document Type: Article

References (21)

1. Passouant O, Mateu P, Commandini M, Brenkle K, Just B. Pulmonary aspergillosis in non-immunocompromised patient with acute respiratory distress syndrome during A (H1N1) infection. Ann Fr Anesth Reanim 2011;30:e75-6.
2. Stevens DA, Melikian GL. Aspergillosis in the 'nonimmunocompromised' host. Immunol Invest 2011;40:751-66.
3. Garcia-Vidal C, Barba P, Arnan M, Moreno A, Ruiz-Camps I, Gudiol C, Ayats J, Ortí G, Carratalà J. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 2011;53:e16-9.
4. Carfagna P, Brandimarte F, Caccese R, Campagna D, Brandimarte C, Venditti M. Occurrence of influenza A(H1N1)v infection and concomitant invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Mycoses 2011;54:549-51.
5. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011;20:156-74.
6. Dutkiewicz R, Hage CA. Aspergillus infections in the critically ill. Proc Am Thorac Soc 2010;7:204-9.
7. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, León C, Alvarez-Lerma F, Nolla-Salas J, Iruretagoyena JR, Barcenilla F. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005;9:R191-9.
8. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004;170:621-5.
9. Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo J, Bistrian BR. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 1997;21:91-5.
10. Janes SM, Barker KF, Mak V, Bell D. Invasive pulmonary aspergillosis in an insulin-dependent diabetic. Respir Med 1998;92:972-5.
11. Grizzanti JN, Knapp A. Diabetic ketoacidosis and invasive aspergillosis. Lung 1981;159:43-9.
12. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock 1999;11:153-9.
13. Guarner J, Falcón-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 2009;40:655-61.
14. Lewis DE, Gilbert BE, Knight V. Influenza virus infection induces functional alterations in peripheral blood lymphocytes. J Immunol 1986;137:3777-81.
15. Astry CL, Jakab GJ. Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis. J Virol 1984;50:287-92.
16. Lee FE, Daigle CC, Urban MA, Metlay LA, Treanor JJ, Trawick DR. Fever and progressive respiratory failure in three elderly family members. Chest 2005;128:1863-4, 1865-7.
17. Adalja AA, Sappington PL, Harris SP, Rimmele T, Kreit JW, Kellum JA, Boujoukos AJ. Isolation of Aspergillus in three 2009 H1N1 influenza patients. Influenza Other Respi Viruses 2011;5:225-9.
18. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010;16:971-3.
19. Kim SH, Kim MN, Lee SO, Choi SH, Kim YS, Woo JH, Lim CM, Koh Y, Hong SB. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses 2012;55:189-92.
20. Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000;79:250-60.
21. Britt RH, Enzmann DR. Clinical stages of human brain abscesses on serial CT scans after contrast infusion. Computerized tomographic, neuropathological, and clinical correlations. J Neurosurg 1983;59:972-89.